ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 08, 2019 19:00 JST
Source:
Holista CollTech Ltd
iGalen and Holista announce resolution with ATM Metabolics
PERTH, W AUSTRALIA, Nov 08, 2019 - (ACN Newswire) - Holista, a research-driven biotech company that develops natural ingredient and wellness products, and its distributor iGalen are pleased to announce that they have resolved their disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.
If you would like to purchase the product in the future, please contact ATM at www.atmmetabolics.com. We wish ATM and Dr. Ahrens success in their future endeavours, and thank them for working with us to resolve the disputes.
Holista CollTech (ASX:HCT) is a research-driven biotech company. Headquartered in Perth with operations in Malaysia, it is dedicated to delivering first-class natural ingredients and wellness products globally. Holista's ingredients include low-GI baked products, reduced-sodium salts, low-fat fried foods and low calorie sugar. www.holistaco.com.
iGalen markets a range of premium-quality nutritional supplements that are sold directly to Distributors and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Singapore, Mexico, Malaysia, and the Philippines. Visit www.igalen.com.
Source: Holista CollTech Ltd
Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
SAKENOVA: 28-Year-Old Master Brewer Pioneers AI-Driven Sake Revolution, Achieving 40% Cost Reduction While Winning International Gold Medals
Dec 15, 2025 23:00 JST
NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport
Dec 15, 2025 19:41 JST
NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz
Dec 15, 2025 19:04 JST
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 08:30 JST
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
Honda to Launch New Heritage Service Business
Dec 12, 2025 20:31 JST
Bank Mandiri Enhances Digital Resiliency for Financial Trading in Indonesia through Advanced Time Sync Solutions with NEC and Adtran Oscilloquartz
Dec 12, 2025 19:59 JST
NEC and ClimateAi sign a Memorandum of Understanding (MoU) for business co-creation to enhance climate resilience across various industries
Dec 12, 2025 18:13 JST
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST
Eisai Rated "A", the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year
Dec 11, 2025 19:41 JST
NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year
Dec 11, 2025 19:00 JST
MHI Successfully Produces Hydrogen at Its Ammonia Cracking Pilot Plant Using Steam Heating
Dec 10, 2025 18:14 JST
NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025
Dec 10, 2025 12:00 JST
"LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List
Dec 09, 2025 18:51 JST
NEC Wins TIP MUST Silver Badge with Advanced Network Operating System for Open Optical Transponders
Dec 09, 2025 13:39 JST
MHI and Worley to Deliver Full-Scale Carbon Capture Facility for Heidelberg Materials UK's Padeswood Cement Works
Dec 08, 2025 17:00 JST
Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
Dec 08, 2025 16:34 JST
MHIET U.S. Subsidiary's Franklin Plant Celebrates 10th Anniversary
Dec 08, 2025 16:03 JST
Lexus World Premieres Lexus LFA Concept BEV Sports Car
Dec 05, 2025 19:13 JST
TOYOTA GAZOO Racing World Premieres GR GT & GR GT3
Dec 05, 2025 18:58 JST
More Latest Release >>
Related Release
Berjaya Partners Holista to Offer Healthy Breads and Foods in Starbucks Malaysia, 7-Eleven and Other F&B Outlets
October 12 2021 17:00 JST
Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment
June 18 2021 14:00 JST
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
October 21 2020 21:00 JST
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
October 01 2020 15:00 JST
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
April 21 2020 06:30 JST
Skin Elements Enters Binding Agreement with Holista Colltech To Launch All Natural Skin-Friendly Sanitiser
April 03 2020 17:00 JST
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
February 20 2020 16:00 JST
Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease
February 06 2020 16:00 JST
Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus
January 30 2020 16:00 JST
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Fat-Soluble Nutraceuticals
December 13 2019 13:00 JST
More Press release >>